MIRA INFORM REPORT

 

 

Report Date :

23.01.2008

 

IDENTIFICATION DETAILS

 

Name :

EKIN MEDIKAL DIS TICARET A.S.

 

 

Registered Office :

Inonu Mah Cimen Sok No:74/1 Harbiye- Istanbul/

 

 

Country :

Turkey

 

 

Financials (as on) :

31.12.2006

 

 

Date of Incorporation :

25.03.2004 (Commercial Registry Gazette Date/No: 30.03.2004/6018 )

 

 

Com. Reg. No.:

519179

 

 

Legal Form :

Private Limited

 

 

Line of Business :

Trade of medical materials

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but Correct

 

 

Litigation :

Clear


COMPANY IDENTIFICATION

 

NAME

:

EKIN MEDIKAL DIS TICARET A.S.

ADDRESS

:

Head Office: Inonu Mah Cimen Sok No:74/1 Harbiye- Istanbul/ Turkey

PHONE NUMBER

:

90-212-291 55 95 (pbx)

FAX NUMBER

:

90-212-291 42 74

 

 

LEGAL STATUS AND HISTORY

 

TAX OFFICE / NO

:

Beyoglu / 3280309752

 

REGISTRATION NUMBER

:

519179

 

REGISTERED OFFICE

:

Istanbul Chamber of Commerce

 

DATE ESTABLISHED

:

25.03.2004 (Commercial Registry Gazette Date/No: 30.03.2004/6018 )

 

LEGAL FORM

:

Joint Stock Company

 

TYPE OF COMPANY

:

Private

 

REGISTERED CAPITAL

:

YTL 500,000

 

PAID-IN CAPITAL

:

YTL 500,000

 

HISTORY

:

 

 

 

 

Previous Registered Capital

: YTL 50,000

 

 

Regist. Capital Changed on

: 07.11.2005 (Commercial Registry Gazette Date/No: 10.11.2005/6428)


OWNERSHIP / MANAGEMENT

 

SHAREHOLDERS

 

:

Aziz Kaya

Duygu Kaya

Ekin Kaya

Ismet Sen

Sema Demirtas

 

65 %

10 %

10 %

10 %

 5 %

SISTER COMPANIES

:

Kultur Saglik Hizmetleri ve Dis Ticaret Ltd Sti.

 

GROUP PARENT COMPANY

 

:

None

SUBSIDIARIES

 

:

None

BOARD OF DIRECTORS

:

 

Aziz Kaya

Ekin Kaya

Ismet Sen

 

Chairman

Member

Member

 

DIRECTORS

:

Aziz Kaya

 

 

OPERATIONS

 

BUSINESS ACTIVITIES

:

Trade of medical materials

 

The firm declared that, it is the distributor of the following companies:

-Diasys Europe (UK)

-Isogen (Netherlands)

-Ivagen (France)

-Ultimed (Germany)

-Oxford Immunotec (UK)

-Invernes Medical (USA)

-Anilab Systems (Finland)

 

SECTOR

 

:

Commerce

NUMBER OF EMPLOYEES

:

4

 

NET SALES

:

(YTL)

635,081

1,239,917

 

(2005)

(2006)

 

CAPACITY

:

None

 

PRODUCTION

:

None

 

 

IMPORT VALUE

:

 

(EUR)

200,000

 

(2006)

 

IMPORT COUNTRIES

:

UK, France…

 

MERCHANDISE IMPORTED

 

:

Medical materials

PREMISES

:

Head Office: Inonu Mah Cimen Sok No:74/1 Harbiye-Istanbul (400 sqm) (owned)

 

FIXED CAPITAL INVESTMENTS

:

None

 

 

TREND OF BUSINESS

:

Upwards in 2006

SIZE OF BUSINESS

:

Lower- moderate

 

 

FINANCE

 

MAIN DEALING BANKERS

:

T.Halk Bankasi Kucukkoy branch in Istanbul

Kuveyt Turk Katilim Bankasi Taksim branch in Istanbul

Yapi ve Kredi Bankasi Harbiye branch in Istanbul

Turk Ekonomi Bankasi Cihangir branch in Istanbul

 

CREDIT FACILITIES

:

The subject company is making use of credit facilities.

 

PAYMENT BEHAVIOUR

:

We are informed about a few payment delays in the last years but most of them were resolved later on.

 

 

 

COMMENT ON FINANCIAL POSITION

 

FINANCIAL STRUCTURE (SUFFICENCY OF OWN RESOURCES)

 

 

In order

 

As of 31.12.2006

 

LIQUIDITY

 

 

In order

 

As of 31.12.2006

PROFITABILITY

 

 

High

In 2006

 

 

GAP BETWEEN COLLECTION-PAYMENT

PERIODS

 

 

Favorable

 

In 2006

 

GENERAL FINANCIAL

POSITION

 

 

In order

 

 

 


CREDIT OPINION

 

 

CREDIT OPINION WITHOUT OBLIGATION

 

:

We are of the opinion that, a max. credit of USD 175,000 may be granted to the subject company.

 

 

 

 

Incr. in producers’ price index

 

Average YTL/$

Average YTL/EUR

Average YTL/GBP

(2005)

2.66 %

1.3499

1.6882

2.4623

(2006)

11.58 %

1.4309

1.7987

2.6377

(1.1.-30.09.2007)

4.98 %

1.3447

1.8084

2.6720

(2007)

5.94 %

1.3075

1.7901

2.6133

 

 

 

                                        
BALANCE SHEETS

 

 

 

YTL

 

 

 

YTL

 

 

 

 

 

31.12.05

 

 

 

31.12.06

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS

822.070

 

0,93

 

1.093.654

 

0,74

 

 

 Cash and Banks

637.094

 

0,72

 

355.918

 

0,24

 

 

 Marketable Securities

0

 

0,00

 

0

 

0,00

 

 

 Account Receivable

43.789

 

0,05

 

144.981

 

0,10

 

 

 Other Receivable

0

 

0,00

 

1.984

 

0,00

 

 

 Inventories

83.519

 

0,09

 

488.483

 

0,33

 

 

 Advances Given

51.760

 

0,06

 

96.212

 

0,07

 

 

 Other Current Assets

5.908

 

0,01

 

6.076

 

0,00

 

 

 

 

 

 

 

 

 

 

 

 

NON-CURRENT ASSETS

60.823

 

0,07

 

377.263

 

0,26

 

 

 Long-term Receivable

0

 

0,00

 

0

 

0,00

 

 

 Financial Assets

0

 

0,00

 

0

 

0,00

 

 

 Tangible Fixed Assets (net)

58.568

 

0,07

 

375.023

 

0,25

 

 

 Intangible Assets

0

 

0,00

 

2.240

 

0,00

 

 

 Other Non-Current Assets

2.255

 

0,00

 

0

 

0,00

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

882.893

 

1,00

 

1.470.917

 

1,00

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

348.091

 

0,39

 

669.137

 

0,45

 

 

 Financial Loans

81.458

 

0,09

 

382.729

 

0,26

 

 

 Accounts Payable

204.471

 

0,23

 

249.109

 

0,17

 

 

 Loans from Shareholders

0

 

0,00

 

0

 

0,00

 

 

 Other Short-term Payable

44.984

 

0,05

 

9.212

 

0,01

 

 

 Advances from Customers

0

 

0,00

 

364

 

0,00

 

 

 Taxes Payable

7.994

 

0,01

 

27.723

 

0,02

 

 

 Provisions

9.184

 

0,01

 

0

 

0,00

 

 

 Other Current Liabilities

0

 

0,00

 

0

 

0,00

 

 

 

 

 

 

 

 

 

 

 

 

LONG-TERM LIABILITIES

0

 

0,00

 

100.043

 

0,07

 

 

 Financial Loans

0

 

0,00

 

100.043

 

0,07

 

 

 Securities Issued

0

 

0,00

 

0

 

0,00

 

 

 Long-term Payable

0

 

0,00

 

0

 

0,00

 

 

 Loans from Shareholders

0

 

0,00

 

0

 

0,00

 

 

 Other Long-term Liabilities

0

 

0,00

 

0

 

0,00

 

 

 Provisions

0

 

0,00

 

0

 

0,00

 

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS' EQUITY

534.802

 

0,61

 

701.737

 

0,48

 

 

 Paid-in Capital

500.000

 

0,57

 

500.000

 

0,34

 

 

 Reserves

9.667

 

0,01

 

32.732

 

0,02

 

 

 Revaluation Fund

2.070

 

0,00

 

2.070

 

0,00

 

 

 Accumulated Losses(-)

0

 

0,00

 

0

 

0,00

 

 

 Net Profit (loss)

23.065

 

0,03

 

166.935

 

0,11

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES AND EQUITY

882.893

 

1,00

 

1.470.917

 

1,00

 

 

 


INCOME STATEMENTS

 

 

 

YTL

 

 

 

YTL

 

 

 

 

 

2005

 

 

 

2006

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Sales

635.081

 

1,00

 

1.239.917

 

1,00

 

 

 Cost of Goods Sold

392.889

 

0,62

 

721.691

 

0,58

 

 

Gross Profit

242.192

 

0,38

 

518.226

 

0,42

 

 

 Operating Expenses

197.658

 

0,31

 

273.125

 

0,22

 

 

Operating Profit

44.534

 

0,07

 

245.101

 

0,20

 

 

 Other Income

1.556

 

0,00

 

12.876

 

0,01

 

 

 Other Expenses

478

 

0,00

 

6.972

 

0,01

 

 

 Financial Expenses

12.662

 

0,02

 

84.070

 

0,07

 

 

Profit (loss) Before Tax

32.950

 

0,05

 

166.935

 

0,13

 

 

 Tax Payable

9.885

 

0,02

 

0

 

0,00

 

 

Net Profit (loss)

23.065

 

0,04

 

166.935

 

0,13

 

 

 

FINANCIAL RATIOS

 

 

 

 

 

 

 

 

 

 

 

 

 

2005

 

 

 

2006

 

 

 

 

LIQUIDITY RATIOS

 

 

 

 

 

 

 

 

 

Current Ratio

2,36

 

 

 

1,63

 

 

 

 

Acid-Test Ratio

1,96

 

 

 

0,75

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ASSET STRUCTURE RATIOS

 

 

 

 

 

 

 

 

 

Inventory/Total Assets

0,09

 

 

 

0,33

 

 

 

 

Short-term Receivable/Total Assets

0,05

 

 

 

0,10

 

 

 

 

Tangible Assets/Total Assets

0,07

 

 

 

0,25

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TURNOVER RATIOS

 

 

 

 

 

 

 

 

 

Inventory Turnover

4,70

 

 

 

1,48

 

 

 

 

Stockholders' Equity Turnover

1,19

 

 

 

1,77

 

 

 

 

Asset Turnover

0,72

 

 

 

0,84

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FINANCIAL STRUCTURE

 

 

 

 

 

 

 

 

 

Stockholders' Equity/Total Assets

0,61

 

 

 

0,48

 

 

 

 

Current Liabilities/Total Assets

0,39

 

 

 

0,45

 

 

 

 

Financial Leverage

0,39

 

 

 

0,52

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PROFITABILITY RATIOS

 

 

 

 

 

 

 

 

 

Net Profit/Stockholders' Eq.

0,04

 

 

 

0,24

 

 

 

 

Operating Profit Margin

0,07

 

 

 

0,20

 

 

 

 

Net Profit Margin

0,04

 

 

 

0,13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COLLECTION-PAYMENT

 

 

 

 

 

 

 

 

 

Average Collection Period (days)

24,82

 

 

 

42,09

 

 

 

 

Average Payable Period (days)

187,35

 

 

 

124,26

 

 

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions